Related Experiment Video
Updated: Oct 15, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Disruption of TGFbeta signaling pathways in human pancreatic cancer cells
D M Simeone1, T Pham, C D Logsdon
1Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA. simeone@umich.edu
Objective:
To investigate whether transforming growth factor beta (TGFbeta) signaling is disrupted in human pancreatic cancer cells, and to study the role of TGFbeta receptors and Smad genes.
Summary Background Data:
TGFbeta is a known inhibitor of pancreatic growth. Disruption of the TGFbeta signaling pathway may play a role in pancreatic cancer development.
Methods:
The effect of TGFbeta on the BxPC-3, MiaPaCa-2, and PANC-1 pancreatic cancer cell lines was evaluated by [3H]thymidine incorporation and a TGFbeta-responsive reporter assay. Expression of TGFbeta receptors and Smads 2 and 3 was assessed by cross-linking assays and reverse transcriptase-polymerase chain reaction (RT-PCR). The ability to restore TGFbeta responsiveness was evaluated by transfection of TGFbeta signaling components.
Results:
TGFbeta produced little inhibition of DNA synthesis and did not activate a TGFbeta-responsive reporter in pancreatic cancer cell lines. 125TGFbeta cross-linking and RT-PCR confirmed the presence of TGFbeta receptors and Smad2 and Smad3 transcripts. Transfection of TGFbeta receptors or Smads 2 and 3 did not restore responsiveness. However, transfection of Smad4 into the BxPC-3 pancreatic cancer cell line restored TGFbeta responsiveness.
Conclusions:
Pancreatic cancer cells show loss of TGFbeta responsiveness. Smads 2 and 3 and TGFbeta receptors are not defective in the cell lines studied. Transfection of Smad4 into one of the cell lines restored TGFbeta responsiveness, suggesting an important role for Smad4 in pancreatic cancer. It is likely that other, as yet unidentified genes are important in TGFbeta resistance in pancreatic cancer cells.
Insights
Transforming growth factor beta (TGFbeta) signaling is disrupted in pancreatic cancer cells, with Smad4 playing a key role in restoring TGFbeta responsiveness and suggesting its importance in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor beta (TGFbeta) is a known inhibitor of pancreatic cell growth.
- Disruption of the TGFbeta signaling pathway is implicated in pancreatic cancer development.
Purpose of the Study:
- To investigate TGFbeta signaling disruption in human pancreatic cancer cells.
- To determine the roles of TGFbeta receptors and Smad genes in this process.
Main Methods:
- Evaluated TGFbeta effects on pancreatic cancer cell lines (BxPC-3, MiaPaCa-2, PANC-1) using [3H]thymidine incorporation and reporter assays.
- Assessed TGFbeta receptor and Smad 2/3 expression via cross-linking and RT-PCR.
- Investigated restoration of TGFbeta responsiveness through transfection of signaling components.
Main Results:
- Pancreatic cancer cell lines exhibited minimal inhibition of DNA synthesis and no reporter activation by TGFbeta.
- TGFbeta receptors and Smad 2/3 transcripts were present.
- Transfection of TGFbeta receptors or Smads 2/3 did not restore TGFbeta responsiveness.
- Transfection of Smad4 restored TGFbeta responsiveness in the BxPC-3 cell line.
Conclusions:
- Pancreatic cancer cells demonstrate a loss of TGFbeta responsiveness.
- Smads 2/3 and TGFbeta receptors are not defective in the studied cell lines.
- Smad4 plays a crucial role in restoring TGFbeta responsiveness in pancreatic cancer, indicating its significance.
- Other unidentified genes likely contribute to TGFbeta resistance in pancreatic cancer.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Canonical Wnt Signaling Pathway

